<DOC>
	<DOC>NCT02422654</DOC>
	<brief_summary>Primary Objective: The purpose of this study is to assess the palatability of eliglustat prototype liquid formulations in healthy subjects.</brief_summary>
	<brief_title>Taste Evaluation of Different Liquid Formulations With Eliglustat</brief_title>
	<detailed_description>The total duration of the study for each subject will be approximately 5 weeks (screening period from Day -28 to Day -2, treatment period of 3 days, and follow-up call on Day 5).</detailed_description>
	<mesh_term>Gaucher Disease</mesh_term>
	<mesh_term>Eliglustat</mesh_term>
	<criteria>Inclusion criteria : Healthy male and female subjects, 18 to 55 years of age, inclusive. Normal smell and taste ability to discriminate odor and flavor differences. Exclusion criteria: Poor metabolizer phenotype status for CYP2D6 (predicted based on genotype). Subject who has smoked within 3 months of inclusion. The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>